Clusterin a potential pathophysiological actor in rheumatoid arthritis

被引：0
|
作者：
Devauchelle, V
Margottin, F
De Pinieux, G
Anract, P
Saraux, A
Breban, M
Dougados, M
Fournier, C
Chiocchia, G
机构：
[1] INSERM, Paris, France
[2] Hosp Cochin, Paris, France
[3] Hosp Cavale Blanche, Brest, France
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S329 / S330
页数：2
相关论文
共 50 条
  • [21] Adipokines as Potential Biomarkers in Rheumatoid Arthritis
    Del Prete, Annalisa
    Salvi, Valentina
    Sozzani, Silvano
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [22] Glycosaminoglycans are a potential cause of rheumatoid arthritis
    Wang, JY
    Roehrl, MH
    FASEB JOURNAL, 2003, 17 (07): : C41 - C41
  • [23] Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: An update
    Toussirot, Eric
    Roudier, Jean
    JOINT BONE SPINE, 2007, 74 (05) : 418 - 426
  • [24] CYTOKINE ACTIVATION AND FORMATION OF NEPHROPATHY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND PATHOPHYSIOLOGICAL PARALLELS
    Rekalov, D.
    Prytkova, G.
    Kulynych, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 929 - 930
  • [25] DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets
    V Devauchelle
    S Marion
    N Cagnard
    S Mistou
    G Falgarone
    M Breban
    F Letourneur
    A Pitaval
    O Alibert
    C Lucchesi
    P Anract
    M Hamadouche
    X Ayral
    M Dougados
    X Gidrol
    C Fournier
    G Chiocchia
    Genes & Immunity, 2004, 5 : 597 - 608
  • [26] Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis
    Buttgereit, Frank
    Doering, Gisela
    Schaeffler, Achim
    Witte, Stephan
    Sierakowski, Stanislaw
    Gromnica-Ihle, Erika
    Jeka, Slawomir
    Krueger, Klaus
    Szechinski, Jacek
    Alten, Rieke
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) : 1275 - 1280
  • [27] DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets
    Devauchelle, V
    Marion, S
    Cagnard, N
    Mistou, S
    Falgarone, G
    Breban, M
    Letourneur, F
    Pitaval, A
    Alibert, O
    Lucchesi, C
    Anract, P
    Hamadouche, M
    Ayral, X
    Dougados, M
    Gidrol, X
    Fournier, C
    Chiocchia, G
    GENES AND IMMUNITY, 2004, 5 (08) : 597 - 608
  • [28] Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use
    Hazes, Johanna M. W.
    Coulie, Pierre G.
    Geenen, Vincent
    Vermeire, Severine
    Carbonnel, Franck
    Louis, Edouard
    Masson, Pierre
    De Keyser, Filip
    RHEUMATOLOGY, 2011, 50 (11) : 1955 - 1968
  • [29] ARGININE-VASOPRESSIN (AVP) SECRETION IN RHEUMATOID-ARTHRITIS - PATHOPHYSIOLOGICAL IMPLICATIONS
    CHIKANZA, IC
    PETROU, P
    PANAYI, GS
    CHROUSOS, G
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 382 - 382
  • [30] Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis
    Aidinis, V
    Carninci, P
    Armaka, M
    Witke, W
    Harokopos, V
    Pavelka, N
    Koczan, D
    Argyropoulos, C
    Thwin, MM
    Möller, S
    Kazunori, W
    Gopalakrishnakone, P
    Ricciardi-Castagnoli, P
    Thiesen, HJ
    Hayashizaki, Y
    Kollias, G
    PLOS GENETICS, 2005, 1 (04) : 455 - 466
12345